Production of stem cells with embryonic characteristics from human umbilical cord blood

Colin P. McGuckin, N. Forraz, M. O. Baradez, S. Navran, J. Zhao, Randall Urban, Ronald Tilton, Larry Denner

Research output: Contribution to journalArticle

176 Citations (Scopus)

Abstract

When will embryonic stem cells reach the clinic? The answer is simple - not soon! To produce large quantities of homogeneous tissue for transplantation, without feeder layers, and with the appropriate recipient's immunological phenotype, is a significant scientific hindrance, although adult stem (ADS) cells provide an alternative, more ethically acceptable, source. The annual global 100 million human birth rate proposes umbilical cord blood (UCB) as the largest untouched stem cell source, with advantages of naive immune status and relatively unshortened telomere length. Here, we report the world's first reproducible production of cells expressing embryonic stem cell markers, - cord-blood-derived embryonic-like stem cells (CBEs). UCB, after elective birth by Caesarean section, has been separated by sequential immunomagnetic removal of nucleate granulocytes, erythrocytes and haemopoietic myeloid/lymphoid progenitors. After 7 days of high density culture in microflasks, (10 5 cells/ml, IMDM, FCS 10%, thrombopoietin 10 ng/ml, flt3-ligand 50 ng/ml, c-kit ligand 20 ng/ml). CBE colonies formed adherent to the substrata; these were maintained for 6 weeks, then were subcultured and continued for a minimum 13 weeks. CBEs were positive for TRA-1-60, TRA-1-81, SSEA-4, SSEA-3 and Oct-4, but not SSEA-1, indicative of restriction in the human stem cell compartment. The CBEs were also microgravity-bioreactor cultured with hepatocyte growth medium (IMDM, FCS 10%, HGF 20 ng/ml, bFGF 10 ng/ml, EGF 10 ng/ml, c-kit ligand 10 ng/ml). After 4 weeks the cells were found to express characteristic hepatic markers, cytokeratin-18, α-foetoprotein and albumin. Thus, such CBEs are a viable human alternative from embryonic stem cells for stem cell research, without ethical constraint and with potential for clinical applications.

Original languageEnglish (US)
Pages (from-to)245-255
Number of pages11
JournalCell Proliferation
Volume38
Issue number4
DOIs
StatePublished - Aug 2005

Fingerprint

Embryonic Stem Cells
Fetal Blood
Stem Cell Factor
Stem Cells
CD15 Antigens
Fetal Proteins
Keratin-18
Feeder Cells
Thrombopoietin
Stem Cell Research
Tissue Transplantation
Weightlessness
Adult Stem Cells
Birth Rate
Telomere
Bioreactors
Granulocytes
Epidermal Growth Factor
Cesarean Section
Hepatocytes

ASJC Scopus subject areas

  • Cell Biology

Cite this

Production of stem cells with embryonic characteristics from human umbilical cord blood. / McGuckin, Colin P.; Forraz, N.; Baradez, M. O.; Navran, S.; Zhao, J.; Urban, Randall; Tilton, Ronald; Denner, Larry.

In: Cell Proliferation, Vol. 38, No. 4, 08.2005, p. 245-255.

Research output: Contribution to journalArticle

McGuckin, Colin P. ; Forraz, N. ; Baradez, M. O. ; Navran, S. ; Zhao, J. ; Urban, Randall ; Tilton, Ronald ; Denner, Larry. / Production of stem cells with embryonic characteristics from human umbilical cord blood. In: Cell Proliferation. 2005 ; Vol. 38, No. 4. pp. 245-255.
@article{565546ec386a42e9ba4a243fe7013db4,
title = "Production of stem cells with embryonic characteristics from human umbilical cord blood",
abstract = "When will embryonic stem cells reach the clinic? The answer is simple - not soon! To produce large quantities of homogeneous tissue for transplantation, without feeder layers, and with the appropriate recipient's immunological phenotype, is a significant scientific hindrance, although adult stem (ADS) cells provide an alternative, more ethically acceptable, source. The annual global 100 million human birth rate proposes umbilical cord blood (UCB) as the largest untouched stem cell source, with advantages of naive immune status and relatively unshortened telomere length. Here, we report the world's first reproducible production of cells expressing embryonic stem cell markers, - cord-blood-derived embryonic-like stem cells (CBEs). UCB, after elective birth by Caesarean section, has been separated by sequential immunomagnetic removal of nucleate granulocytes, erythrocytes and haemopoietic myeloid/lymphoid progenitors. After 7 days of high density culture in microflasks, (10 5 cells/ml, IMDM, FCS 10{\%}, thrombopoietin 10 ng/ml, flt3-ligand 50 ng/ml, c-kit ligand 20 ng/ml). CBE colonies formed adherent to the substrata; these were maintained for 6 weeks, then were subcultured and continued for a minimum 13 weeks. CBEs were positive for TRA-1-60, TRA-1-81, SSEA-4, SSEA-3 and Oct-4, but not SSEA-1, indicative of restriction in the human stem cell compartment. The CBEs were also microgravity-bioreactor cultured with hepatocyte growth medium (IMDM, FCS 10{\%}, HGF 20 ng/ml, bFGF 10 ng/ml, EGF 10 ng/ml, c-kit ligand 10 ng/ml). After 4 weeks the cells were found to express characteristic hepatic markers, cytokeratin-18, α-foetoprotein and albumin. Thus, such CBEs are a viable human alternative from embryonic stem cells for stem cell research, without ethical constraint and with potential for clinical applications.",
author = "McGuckin, {Colin P.} and N. Forraz and Baradez, {M. O.} and S. Navran and J. Zhao and Randall Urban and Ronald Tilton and Larry Denner",
year = "2005",
month = "8",
doi = "10.1111/j.1365-2184.2005.00346.x",
language = "English (US)",
volume = "38",
pages = "245--255",
journal = "Cell Proliferation",
issn = "0960-7722",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Production of stem cells with embryonic characteristics from human umbilical cord blood

AU - McGuckin, Colin P.

AU - Forraz, N.

AU - Baradez, M. O.

AU - Navran, S.

AU - Zhao, J.

AU - Urban, Randall

AU - Tilton, Ronald

AU - Denner, Larry

PY - 2005/8

Y1 - 2005/8

N2 - When will embryonic stem cells reach the clinic? The answer is simple - not soon! To produce large quantities of homogeneous tissue for transplantation, without feeder layers, and with the appropriate recipient's immunological phenotype, is a significant scientific hindrance, although adult stem (ADS) cells provide an alternative, more ethically acceptable, source. The annual global 100 million human birth rate proposes umbilical cord blood (UCB) as the largest untouched stem cell source, with advantages of naive immune status and relatively unshortened telomere length. Here, we report the world's first reproducible production of cells expressing embryonic stem cell markers, - cord-blood-derived embryonic-like stem cells (CBEs). UCB, after elective birth by Caesarean section, has been separated by sequential immunomagnetic removal of nucleate granulocytes, erythrocytes and haemopoietic myeloid/lymphoid progenitors. After 7 days of high density culture in microflasks, (10 5 cells/ml, IMDM, FCS 10%, thrombopoietin 10 ng/ml, flt3-ligand 50 ng/ml, c-kit ligand 20 ng/ml). CBE colonies formed adherent to the substrata; these were maintained for 6 weeks, then were subcultured and continued for a minimum 13 weeks. CBEs were positive for TRA-1-60, TRA-1-81, SSEA-4, SSEA-3 and Oct-4, but not SSEA-1, indicative of restriction in the human stem cell compartment. The CBEs were also microgravity-bioreactor cultured with hepatocyte growth medium (IMDM, FCS 10%, HGF 20 ng/ml, bFGF 10 ng/ml, EGF 10 ng/ml, c-kit ligand 10 ng/ml). After 4 weeks the cells were found to express characteristic hepatic markers, cytokeratin-18, α-foetoprotein and albumin. Thus, such CBEs are a viable human alternative from embryonic stem cells for stem cell research, without ethical constraint and with potential for clinical applications.

AB - When will embryonic stem cells reach the clinic? The answer is simple - not soon! To produce large quantities of homogeneous tissue for transplantation, without feeder layers, and with the appropriate recipient's immunological phenotype, is a significant scientific hindrance, although adult stem (ADS) cells provide an alternative, more ethically acceptable, source. The annual global 100 million human birth rate proposes umbilical cord blood (UCB) as the largest untouched stem cell source, with advantages of naive immune status and relatively unshortened telomere length. Here, we report the world's first reproducible production of cells expressing embryonic stem cell markers, - cord-blood-derived embryonic-like stem cells (CBEs). UCB, after elective birth by Caesarean section, has been separated by sequential immunomagnetic removal of nucleate granulocytes, erythrocytes and haemopoietic myeloid/lymphoid progenitors. After 7 days of high density culture in microflasks, (10 5 cells/ml, IMDM, FCS 10%, thrombopoietin 10 ng/ml, flt3-ligand 50 ng/ml, c-kit ligand 20 ng/ml). CBE colonies formed adherent to the substrata; these were maintained for 6 weeks, then were subcultured and continued for a minimum 13 weeks. CBEs were positive for TRA-1-60, TRA-1-81, SSEA-4, SSEA-3 and Oct-4, but not SSEA-1, indicative of restriction in the human stem cell compartment. The CBEs were also microgravity-bioreactor cultured with hepatocyte growth medium (IMDM, FCS 10%, HGF 20 ng/ml, bFGF 10 ng/ml, EGF 10 ng/ml, c-kit ligand 10 ng/ml). After 4 weeks the cells were found to express characteristic hepatic markers, cytokeratin-18, α-foetoprotein and albumin. Thus, such CBEs are a viable human alternative from embryonic stem cells for stem cell research, without ethical constraint and with potential for clinical applications.

UR - http://www.scopus.com/inward/record.url?scp=23844523442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844523442&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2184.2005.00346.x

DO - 10.1111/j.1365-2184.2005.00346.x

M3 - Article

C2 - 16098183

AN - SCOPUS:23844523442

VL - 38

SP - 245

EP - 255

JO - Cell Proliferation

JF - Cell Proliferation

SN - 0960-7722

IS - 4

ER -